FDA Enhances Warnings on Fluoroquinolone Antibiotics

Share it with your friends Like

Thanks! Share it with your friends!

Close

By Julie Fidler

On July 26, the U.S. Food and Drug Administration (FDA) bolstered the warnings concerning a certain class of antibiotics, called fluoroquinolones, saying they’re too strong for bronchitis, sinus infections, and simple urinary tract infections.

Levofloxacin (brand name Levaquin) and ciprofloxacin (brand name Cipro) are both examples of commonly prescribed fluoroquinolones. These drugs are associated with serious and long-lasting side effects. A good friend of mine suffers from permanent neuropathy in her hands as a result of taking Cipro several years ago.

The FDA said in a statement:

“While these drugs are effective in treating serious bacterial infections, an FDA safety review found …read more

Read more here: naturalsociety.com

    

  • Rating:
  • Views:330 views
  • Categories: Health